Favorable Response to Mirtazapine in John Cunningham Virus-related Gray Matter Lesion in a Patient with Human Immunodeficiency Virus

Mirtazapine has recently emerged as a promising agent for the treatment of progressive multifocal leukoencephalopathy (PML). While there is no Class I evidence for its use, numerous case reports have illustrated mirtazapine’s efficacy. True to its name, PML is known to occur mostly in the white matt...

Descripción completa

Detalles Bibliográficos
Autores principales: Alwehaibi, Abdullah I, AlJaber, Mohammed I, Nahrir, Shahpar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2019
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516628/
https://www.ncbi.nlm.nih.gov/pubmed/31131178
http://dx.doi.org/10.7759/cureus.4255

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516628/
https://www.ncbi.nlm.nih.gov/pubmed/31131178
http://dx.doi.org/10.7759/cureus.4255

Ejemplares similares